David A. Schoenfeld
Affiliations: | Biostatistics | Harvard University, Cambridge, MA, United States |
Area:
Biostatistics BiologyGoogle:
"David Schoenfeld"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Smith SM, Dworkin RH, Turk DC, et al. (2020) Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain |
| Casey JD, Johnson NJ, Semler MW, et al. (2020) Rationale and Design of ORCHID: A Randomized Placebo-Controlled Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. Annals of the American Thoracic Society |
| Novack V, Beitler JR, Yitshak-Sade M, et al. (2020) Alive and Ventilator Free: A Hierarchical, Composite Outcome for Clinical Trials in the Acute Respiratory Distress Syndrome. Critical Care Medicine. 48: 158-166 |
| Dichtel LE, Carpenter LL, Nyer M, et al. (2020) SAT-737 Low-Dose Testosterone Augmentation for Treatment-Resistant Depression in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study Journal of the Endocrine Society. 4 |
| Babu S, Macklin EA, Jackson KE, et al. (2019) Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9 |
| Schoenfeld DA, Finkelstein DM, Macklin E, et al. (2019) Design and analysis of a clinical trial using previous trials as historical control. Clinical Trials (London, England). 1740774519858914 |
| Finkelstein DM, Schoenfeld DA. (2019) Graphing the Win Ratio and its components over time. Statistics in Medicine. 38: 53-61 |
| Paganoni S, Alshikho MJ, Luppino S, et al. (2018) A Pilot Trial of RNS60 in Amyotrophic Lateral Sclerosis. Muscle & Nerve |
| Wise RA, Chapman KR, Scirica BM, et al. (2018) Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study. Chronic Obstructive Pulmonary Diseases (Miami, Fla.). 5: 5-15 |
| Fournier CN, Schoenfeld D, Berry JD, et al. (2018) An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8 |